It hasn't been confirmed and doesn't seem too likely to me, at least not anytime soon. Their current job listing for a histotechnician requires someone who lives and works in the US.So has it been confirmed that stemson will be conducting the trials in the UK? I hear this mentioned alot but don't understand the reasoning. We don't have expedited clinical trials, we have specials (that HairClone are pursuing) but I'm unsure if Stemson will be able to take advantage of that route as they're for medicinals, even if they could I'm not sure who'd be willing to pay for it without evidence of it working in humans.
Would be interested to see what they discussed at the fortunis event/presentation held recently.
Perhaps Fortunis Capital wanted them to post it to hype themselves up as well? Fortunis comes off to me as another fairly small company trying to make themselves up to be far bigger than they are. From what they've done so far it doesn't seem like they'd actually be able to offer Stemson much meaningful help in getting a potential cure out.
Last edited: